Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis
S. Terraneo (Milan, Italy), F. Di Marco (Milan, Italy), G. Imeri (Milan, Italy), L. Giuliani (Milan, Italy), S. Ancona (Milan, Italy), P. Cetrangolo (Milan, Italy), E. Grasso (Milan, Italy), S. Centanni (Milan, Italy), E. Lesma (Milan, Italy)
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Session: Progress in rare interstitial lung diseases
Session type: Oral Presentation
Number: 3785
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Terraneo (Milan, Italy), F. Di Marco (Milan, Italy), G. Imeri (Milan, Italy), L. Giuliani (Milan, Italy), S. Ancona (Milan, Italy), P. Cetrangolo (Milan, Italy), E. Grasso (Milan, Italy), S. Centanni (Milan, Italy), E. Lesma (Milan, Italy). Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis. 3785
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009
Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis Source: Eur Respir Rev 2012 21:196-206 Year: 2012
Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004
Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006
Serum levels of vascular endothelial growth factor in the differential diagnosis of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002
Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010
Vascular endothelial growth factor modulates matrix metalloproteinase-9 expression in asthma Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006
Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006
Matrix metalloproteinases, as markers of the severity of idiopathic pulmonary fibrosis Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 834-842 Year: 2005
IGFBP-2: a new pathway in systemic sclerosis associated interstitial lung disease Source: International Congress 2019 – Connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis: what’s new? Year: 2019
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis Source: Eur Respir J 2009; 34: 1376-1382 Year: 2009
Serum VEGF-D and VEGFR-3 are biomarkers in lymphangioleiomyomatosis for its diagnosis and impaired pulmonary function Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
Circulating vascular endothelial growth factor and osteoporosis in patients with COPD Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010
Matrix metalloproteinases (MMPs) and angiogenesis in lung tissue remodeling in different variants of idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2007; 30: Suppl. 51, 137s Year: 2007
Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Abnormalities between down regulation of cyclooxygenase-2 and up-regulation of grow factors in patients with systemic sclerosis Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Concentration of serum vascular endothelial growth factor D and its correlation with functional and clinical variables in patients with lymphangioleiomyomatosis from a Brazilian reference centre Source: International Congress 2017 – Rare diseases Year: 2017
Expression of hyaluronidase by interstitial myofibroblasts and epithelial cells is associated with fibrosis extension, clinical forms and pulmonary function stage in patients with systemic sclerosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010